Skip to main content
. Author manuscript; available in PMC: 2009 Aug 20.
Published in final edited form as: AIDS. 2008 Aug 20;22(13):1601–1609. doi: 10.1097/QAD.0b013e32830a502e

Table 3.

Difference in CD4 counts and HIV-1 RNA levels in treatment arm versus placebo arm.

Average difference in CD4 count between albendazole and placebo groups at 12 weeks follow-up (95%CI) P value Average difference in Log10 HIV-1 RNA between albendazole and placebo groups at 12 weeks follow-up (95%CI) P value
All ITT individuals
(n=208) 		+37.0 cells/mm3 (−4.6 to +78.7) 0.08 −0.11 log10 copies/mL (−0.37 to +0.15) 0.42
Ascaris lumbricoides
(n=54) 		+109.0 cells/mm3 (+38.9 to +179.0) 0.003 −0.54 log10 copies/mL (−1.17 to +0.09) 0.09
Hookworm
(n=148) 		+11.9 cells/mm3 (−36.6 to 60.3) 0.63 +0.001 log10 copies/mL (−0.30 to +0.30) 1.00
Trichuris trichiura
(n=24) 		+35.6 cells/mm3 (−135.3 to +206.5) 0.67 +0.31 log10 copies/mL (−0.49 to +1.10) 0.43
Mixed Infection
(n=19) 		+24.2 cells/mm3 (−124.0 to +172.5) 0.73 −0.32 log10 copies/mL (−1.68 to +1.03) 0.62